CSF1R and glioblastoma: Strategies targeting TAMs focus on blocking recruitment via CCL2-CCR2 inhibition, promoting M1 polarization via CD47-SIRPα blockade, or depleting M1 polarization via CSF-1R inhibitors.375,376 These approaches have demonstrated preclinical efficacy but require further validation in GBM patients.